BRM undiluted NAV as at 11/1/23 - $0.6740

MKTUPDTE
Thu, Jan 12 2023 01:06 pm

BRM undiluted NAV as at 11/1/23 - $0.6740

Date 11/1/2023 4/1/2023
BRM undiluted NAV $0.6740 $0.6637
Share price close $0.69 $0.71
(Premium) (2%) (7%)

The above net asset value (NAV) is unaudited and net of fees and tax.
The NAV per share is calculated after deducting treasury stock (shares acquired under the Barramundi buyback programme) - currently nil.

* The undiluted NAV excludes any impact on the NAV of the future exercise of warrants (BRMWG). At 11 January 2023, 66,682,342 warrants are on issue and may be exercised on 26 May 2023. The actual exercise price of each warrant is $0.89 less the dividends per share declared by the company with a record date between 16 May 2022 and the announcement of the 26 May 2023 exercise price. Dividends totalling 4.25 cents per share have been declared to date and there is one more dividend expected to be declared in the remaining period up to the announcement of the 26 May 2023 exercise price.
The five largest portfolio holdings at 11 January 2023 are approximately as follows:
CSL 9%
Carsales.com 6%
WiseTech 6%
AUB Group 5%
Dominos 5%


BACKGROUND
Barramundi is a listed investment company that invests in growing Australian companies. The Barramundi portfolio is managed by Fisher Funds, a specialist investment manager with a track record of successfully investing in growth company shares. The aim of Barramundi is to offer investors competitive returns through capital growth and dividends, and access to a diversified portfolio of investments through a single tax-efficient investment vehicle. Barramundi listed on the NZX Main Board on 26 October 2006 and may invest in companies that are listed on an Australian stock exchange or unlisted companies.

Contact
Corporate Manager
Barramundi Limited
Tel +64 9 4840352


Announcement PDF


Markets News

Straker AI transition picks up pace
Markets

Straker AI transition picks up pace

Shares were up 4% on the ASX after the result.

Markets Market Close

Investors pause for RBNZ as NZX trades flat

Markets were quiet ahead of Fisher & Paykel Healthcare's earnings on Wednesday. 

Gregor Thompson 27 May 2025
Investors pause for RBNZ as NZX trades flat
Markets

Tait states intention to buy Vital

Vital shares jumped 27% when it resumed trading.

Gregor Thompson 27 May 2025
Tait states intention to buy Vital